Swan EndoSurgical develops robotic platforms for endoluminal surgery, enhancing surgeon precision and control during minimally invasive procedures. Their systems offer advanced articulation and intuitive control to enable more complex interventions within the gastrointestinal tract and other lumens.
Funding
Funding not disclosed
Founders
Product
Problem
Current endoluminal surgical procedures often require significant surgeon manipulation and can be limited by the dexterity and visualization available through traditional endoscopic tools. This can lead to longer procedure times and increased risk of complications for patients undergoing complex interventions.
Solution
Swan EndoSurgical is developing a suite of endoluminal surgical robotic platforms designed to augment surgeon capabilities during minimally invasive procedures. These systems aim to provide enhanced precision, stability, and articulation within the gastrointestinal tract and other lumens. By leveraging advanced robotics, Swan EndoSurgical seeks to enable more complex interventions to be performed endoscopically, potentially reducing the need for open surgery and improving patient recovery. The technology focuses on translating surgeon intent into precise robotic movements, offering a more intuitive and controlled surgical experience.
Target Audience
The primary target audience includes gastroenterologists, thoracic surgeons, and interventional endoscopists seeking to expand their minimally invasive procedural capabilities.
Features
- Articulated robotic endoscope with multi-degree-of-freedom manipulation
- Integrated high-definition imaging and illumination systems
- Force feedback and haptic control for enhanced tactile sensation
- Modular platform designed for various gastrointestinal and pulmonary interventions
- Software architecture supporting advanced navigation and instrument control algorithms
- Potential for integration with AI-driven surgical guidance systems